about
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administ...
Read More
0.80
-0.03
(-3.61%)
2,538
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Immuron Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..